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Abstract
Introduction
The primary objectives of this study were 1) to examine trends of
self-reported cognitive impairment among 5 major racial/ethnic
groups during 1997–2015 in the United States and 2) to examine
differences in the trends across these groups.
Methods
Data were from the National Health Interview Survey (NHIS).
The sample consisted of 155,682 people aged 60 or older. Re-
spondents were asked to report whether any family member was
“limited in any way because of difficulty remembering or because
of experiencing periods of confusion.” Race/ethnicity categories
were non-Hispanic white, non-Hispanic black, Native American,
Hispanic, and Asian. We applied hierarchical age–period–cohort
cross-classified random-effects models for the trend analysis. All
analyses accounted for the complex survey design of NHIS.
Results
The overall rate of self-reported cognitive impairment increased
from 5.7% in 1997 to 6.7% in 2015 (P for trend <.001). Among
non-Hispanic white respondents, the rate increased from 5.2% in
1997 to 6.1% in 2015 (slope = 0.14, P for trend <.001). We ob-
served no significant trend in rate of cognitive impairment in oth-
er groups. After we controlled for covariates, we found that Asian
(B = 0.31), non-Hispanic black (B = 0.37), Hispanic (B = 0.25),
and Native American (B = 0.87) respondents were more likely
than non-Hispanic white respondents to report cognitive impair-
ment (P <.001 for all).
Conclusion
We found an increased rate of self-reported cognitive impairment
in older adults of 5 major racial/ethnic groups from 1997 through
2015 in the United States. However, the rate of self-reported cog-
nitive impairment was low, which may suggest underreporting.
There is a need to further promote awareness of the disease among
individuals, family members, and health care providers.
Introduction
The aging population is increasing rapidly in the United States.
The size of the US population aged 65 or older is projected to be
88.5 million in 2050, more than double the size of this population
(40.2 million) in 2010 (1). The population of older adults will also
become more racially and ethnically diverse. By 2050, the propor-
tion of white older adults will account for 77% of the population
aged 65 or older, down from 87% in 2010, whereas the proportion
for  black older  adults  will  be  12% (9% in  2010),  Asian older
adults 9% (3% in 2010), and Hispanic older adults 20% (7% in
2010) (1).
With the rapid increase in the population of older adults, the size
of the population with cognitive impairment and dementia will ex-
pand (2). Approximately 5.5 million Americans had Alzheimer’s
disease in 2017. This number is expected to grow to 13.8 million
by 2050 (3). The age-adjusted death rate of Alzheimer’s disease in
the United States increased by 54.5% from 1999 to 2014, from
16.5 per 100,000 population to 25.4 per 100,000 population. Sig-
nificant increases occurred in all age groups, both sexes, and all
racial/ethnic groups (4).
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Cognitive impairment may be a precursor to dementia (5). Early
detection of cognitive impairment would facilitate timely medical
treatments,  appropriate  care  planning,  and  prevention  efforts,
which would ultimately reduce health care costs. Data on self-re-
ported cognitive  impairment  are  limited (6–8).  Most  previous
studies have evaluated cognitive impairment by using screening
tests or clinical examination (9–11). Some studies reported racial/
ethnic disparities in cognitive impairment in the United States
(12–14). Older African American adults are about twice as likely
and older Hispanic adults are about 1.5 times as likely to have
Alzheimer’s disease or other dementias as older non-Hispanic
white adults (15). An important limitation of previous research on
cognitive functioning is that it focused mostly on 3 racial/ethnic
groups (white, black, and Hispanic) or fewer (14). No studies have
examined the rate and trend of cognitive impairment in Asian or
Native American adults in the United States. Information on the
cognitive health for subpopulations is needed for health planning
and delivery of  culturally competent  services.  Hence,  new re-
search is warranted to assess the rate of cognitive impairment in
various racial/ethnic groups in the United States.
This study aimed to fill the gap in the literature by using data from
a nationally representative population-based survey, the National
Health Interview Survey (NHIS) (16). The objectives of the study
were 1) to examine the trends in rate of self-reported cognitive
impairment among American adults aged 60 or older in 5 major
racial/ethnic groups from 1997 through 2015 and 2) to examine
differences in trends of self-reported cognitive impairment across
these racial/ethnic groups.
Methods
We collected data on the following racial/ethnic groups: non-His-
panic white, non-Hispanic black, Hispanic, Native American, and
Asian. Data were from the NHIS, a cross-sectional household in-
terview survey conducted annually by the National  Center  for
Health Statistics, which is part of the Centers for Disease Control
and Prevention (CDC). NHIS obtains information through in-per-
son interviews with household respondents to monitor the health
of  the  US population.  The  multistage  area  probability  design
provides a representative sample of the civilian noninstitutional-
ized population residing in the United States at the time of the in-
terviews. The analytical sample for this study included 155,682
adults  aged 60 or  older  in  the NHIS adult  samples from 1997
through 2015.
The outcome variable was self-reported cognitive impairment. In
the NHIS family health status and limitation questionnaire, re-
spondents are asked whether anyone in the household has a limita-
tion in his or her everyday activities (eg, activities of daily living,
instrumental activities of daily living, play, school, and work; dif-
ficulties in walking or in remembering) as a result of a physical,
mental, or emotional health problem. The responses may be self-
reported or reported by an adult household member or by proxy
for other household members not present at  the interview. We
classified a person as having cognitive impairment if the answer
was yes to the question on “limited in any way because of diffi-
culty remembering or because of experiencing periods of confu-
sion.” This measure provides reliable estimates of cognitive status
(17). (Another related NHIS question asks about cognitive impair-
ment  due  to  senility;  that  is,  a  limitation  due  to  senility,
Alzheimer’s disease, or another aging-related cognitive impair-
ment. We did not use this measure in our analysis because of the
small sample sizes, particularly for racial/ethnic minority groups.)
We used 3 sociodemographic variables as covariates: age (60–64
y, 65–69 y, 70–74 y, 75–79 y, 80–84 y, and ≥85 y), sex (male or
female), and marital status (married or living with partner vs oth-
erwise). We also used 2 variables of socioeconomic status as cov-
ariates: education level (some college or more vs others) and fam-
ily income level. Family income was defined as the ratio of total
family income to the federal poverty level (FPL), which was cal-
culated as the family’s income in the most recent calendar year di-
vided by the applicable poverty threshold based on the size of the
family. We classified this poverty ratio variable into 4 categories:
less than 150% of the FPL, 150% to 249% of the FPL, 250% to
499% of the FPL, and 500% or more of the FPL.
In addition, we used 2 health-related variables as covariates. We
collected data on whether or not (yes or no) respondents self-re-
ported the following 5 diseases: heart attack, diabetes, high blood
pressure, coronary heart disease, and stroke. We also collected
data on body mass index (BMI), defined as weight in kilograms
divided by height in meters squared (kg/m2), and we used the fol-
lowing BMI categories (18): underweight (<18.5 kg/m2), normal
weight  (18.5–24.9 kg/m2),  overweight  (25.0–29.9 kg/m2),  and
obese (≥30.0 kg/m2).
Period and birth cohort were also included as covariates. The peri-
od was the survey year — the 19 waves of NHIS surveys from
1997 through 2015. We created 9 birth cohorts with 5- or 6-year
intervals from 1912–1917 to 1953–1957.
We first calculated the rate of cognitive impairment in the various
age groups, survey periods, and birth cohorts in the 5 racial/ethnic
groups and assessed the significance of the slopes of trend lines
(19). Because of the small sample size of Native American adults
in each wave of NHIS, we calculated 3-year moving average rates
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of cognitive impairment (2-year at both end points: 1997–1998 for
the first period, 2014–2015 for the last period, and 3-year for the
middle periods), and we used the average of the survey weight
variable according to 2 or 3 years included. In addition, we com-
pared the slopes of trend lines of period (survey year) to assess the
difference in the rate of change over time by using t tests.
Second, because NHIS data are cross-sectional, to control for age,
survey period, and birth cohort effects, we applied the hierarchical
age–period–cohort (HAPC) cross-classified random-effects model
(CCREM) (20) to examine the trends of cognitive impairment.
Data analyses were conducted by using SAS PROC GLIMMIX
(21) with DIST=binary. The HAPC–CCREM model can effect-
ively estimate any random clustering effects at higher-level cross-
classified units such as survey periods and birth cohorts (20). Pre-
dicted probability  of  self-reported cognitive impairment  (con-
trolling for all covariates) was estimated for the 5 racial/ethnic
groups by age group and birth cohort. We used sampling weights
in analyses. A more conservative level of significance was set at
.01, instead of the standard .05 level, to account for multiple pair-
wise comparisons to a reference category using a Bonferroni cor-
rection (0.05/5 = 0.01) (22).
In the HAPC–CCREM model, age effects refer to variation associ-
ated with different age groups, reflect biological and social pro-
cesses of aging internally to individuals, and represent develop-
mental  changes  during  the  life  course.  Period  effects  refer  to
changes in social, economic, technological, or physical environ-
ments affecting all age groups simultaneously at the time health is
measured. Finally, cohort effects refer to variation among persons
in different birth cohorts. A person in a given birth cohort experi-
ences the same historical and social events at various stages of his
or her life course as other people in that birth cohort. Thus, not
taking into account cohort effects would possibly lead to biased
estimate of trends of social inequalities in the outcome of interest
(20).
Results
Among the 5 racial/ethnic groups, the non-Hispanic white group
was the oldest, and the Hispanic group the youngest. Asian re-
spondents had the largest proportion of adults who had some col-
lege or more (62.1%) and were married or living with a partner
(70.4%) (Table 1). Hispanic respondents had the lowest family in-
come: 65.6% were in the first or second income categories. The
rates of high blood pressure (71.5%) and obesity (38.4%) were
highest among non-Hispanic black respondents. Native American
respondents had the highest rates of heart attack (14.2%), diabetes
(31.4%), coronary heart disease (16.6%), and stroke (10.9%).
The overall rate of self-reported cognitive impairment increased
from 5.7% (95% confidence interval, 5.2%–6.3%) in 1997 to 6.7%
(6.1%–7.3%) (P for trend <.001). The rate increased from 5.2% in
1997 to 6.1% in 2015 among non-Hispanic white respondents (P
for trend < .001).  We found no significant  trends in cognitive
impairment among non-Hispanic black, Native American, Hispan-
ic, or Asian respondents (Table 2).
We found no significant differences in the rate of change in slopes
between non-Hispanic white and non-Hispanic black respondents
(t = 0.24, P = .81), non-Hispanic white and Hispanic respondents
(t = 0.18, P = .86), or non-Hispanic white and Asian respondents (t
= 0.17, P = .10). We did not compare the slope of non-Hispanic
white respondents and Native American respondents because rates
for Native American respondents were calculated in 3-year mov-
ing averages.
Overall, the rate of cognitive impairment increased with age in all
5 racial/ethnic groups (P < .01 for all groups), with a sharper in-
crease in those 85 years or older (Figure 1). Across the 9 birth co-
horts, the rate was lowest among non-Hispanic white respondents
until the 1943–1947 birth cohort, when the rate among Asian re-
spondents was similar to the rate among non-Hispanic white re-
spondents (Figure 2).
Figure 1. Predicted probability of reporting cognitive impairment, by age group.
Data are from the National Health Interview Survey, 1997–2015.
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Figure 2.  Predicted probability  of  reporting cognitive impairment,  by birth
cohort. Data are from the National Health Interview Survey, 1997–2015.
 
In the HAPC–CCREM model, compared with non-Hispanic white
respondents, non-Hispanic black respondents (B = 0.37, P < .001),
Native American respondents (B = 0.87, P < .001), Hispanic re-
spondents (B = 0.25, P < .001), and Asian respondents (B = 0.31,
P < .001) were more likely to report cognitive impairment (Table
3). Parameter estimates on all other covariates were significant (P
< .001): lower education level; lower family income level; having
a heart attack, diabetes, high blood pressure, coronary heart dis-
ease, or stroke; and underweight were all risk factors of cognitive
impairment. The interaction term race/ethnicity by some college or
more was significant for all groups, indicating that college educa-
tion reduced the odds of having cognitive impairment, except for
the Hispanic group.
Overall, the survey period had a significant random effect (B =
0.01, P = .001). The birth cohort 1918–1922 had negative effects,
whereas the birth cohorts 1948–1952 and 1953–1957 had positive
effects. However, the overall random cohort effects were not sig-
nificant (Table 3).
Discussion
To our knowledge, our study is the first to provide a national trend
estimate on self-reported cognitive impairment among non-His-
panic white, non-Hispanic black, Hispanic, Native American, and
Asian adults aged 60 or older in the United States from 1997 to
2015. Our findings indicate a significant increasing trend in self-
reported cognitive impairment. Racial/ethnic differences in self-re-
ported cognitive impairment persisted throughout the study period;
the rate of self-reported cognitive impairment was lowest among
non-Hispanic white adults.
A study in 2014 analyzed the same NHIS data and found that cog-
nitive impairment in adults aged 18 or older increased from 2.0%
in 1998 to 3.3% in 2011 (8), but cognitive impairment was not a
focus, and the study covered a shorter period (8).
It is interesting that our data showed an increasing trend in self-re-
ported cognitive impairment in adults aged 60 or older. Other re-
cent studies that used data from cognitive tests and clinical assess-
ments found a declining trend in dementia in the United States
(9,23). A report in 2016 on the Framingham Heart Study showed
that the temporal trends of incidence of dementia among parti-
cipants  aged  60  or  older  declined  by  about  20%  per  decade
between 1977 and 2008: the 5-year age- and sex-adjusted demen-
tia rates were 3.6% during 1977–1983, 2.8% during 1986–1991,
2.2% during 1992–1998, and 2.0% during 2004–2008 (10). In ad-
dition, an analysis of Health and Retirement Study (HRS) data
found that the prevalence of cognitive impairment with no demen-
tia in adults aged 65 or older decreased significantly from 21.2%
in 2000 to 18.8% in 2012 (9). The HRS assesses cognitive func-
tion by using a multidimensional measure based on a modified
version of the Telephone Interview Cognitive Screen and tests of
immediate and delayed verbal recalls (9).
Nevertheless,  it  is  not appropriate to make direct  comparisons
among these studies because of differences in definitions, opera-
tionalization of cognitive impairment, and study designs. The sig-
nificant increasing trend of self-reported cognitive impairment
found in  our  study might  suggest  that  awareness  of  cognitive
impairment has improved in the United States, especially in re-
cent years (ie, after 2010). The heightened public attention to and
interest in Alzheimer’s disease might have contributed to the in-
creased awareness. Indeed, efforts to improve awareness and per-
ception of cognitive health has been ongoing, including CDC’s
and the Alzheimer’s Association’s Health Brain Initiative,  the
Alzheimer’s Association’s Maintain Your Brain workshops and
community-based demonstration projects to promote cognitive
health, and initiatives by the American Association of Retired Per-
sons (24).
Several factors should be considered when interpreting our find-
ings on the increasing trend of cognitive impairment. First, regard-
less of the increasing trend, an overall rate, ranging from 4.7% to
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6.7% during the study period, may be underreported. When we
analyzed data on a subset of our sample (those aged 65 or older),
the rate of self-reported cognitive impairment was 6.3% in 2000
and 7.5% in 2012. These rates are still lower than the rates shown
by HRS data for the same age group (21.2% in 2000 and 18.8% in
2012) (9).
Second, we found an increasing trend in cognitive impairment
only  among non-Hispanic  white  adults.  Overall,  racial/ethnic
minority groups in our study had higher rates of self-reported cog-
nitive impairment than did the non-Hispanic white group. Public
education is needed to promote awareness of this disease, espe-
cially among racial/ethnic minority groups, who may have differ-
ent cultural beliefs and perceptions of disease and aging than non-
Hispanic white groups (25). Members of racial/ethnic minority
groups may be less likely to seek treatment for psychiatric symp-
toms because of lack of access to care and/or cultural stigmatiza-
tion (26). Moreover, racial/ethnic minority populations may be
less likely than the non-Hispanic white population to accept treat-
ment for depression (27). If the symptoms of depression are left
untreated, cognitive health and quality of life may decline.
Third, the HAPC model results showed racial/ethnic disparities:
racial/ethnic minority adults were more likely than non-Hispanic
white adults to report cognitive impairment. These findings are
consistent with previous findings indicating that white adults were
less likely to have cognitive impairment than black or Hispanic
adults (12,13). A recent study that used HRS data found that His-
panic and black adults had lower levels of cognitive function than
white adults: in a cognitive test having a maximum score of 27
points, Hispanic adults scored 13.7, black adults scored 13.3, and
white adults scored 16.3 (12). In addition, consistent with prior re-
search, our study showed that diseases such as diabetes and stroke
were  associated  with  higher  odds  of  self-reported  cognitive
impairment (28). The persistent racial/ethnic disparities in chronic
disease risk factors may partially account for the higher rate of
cognitive impairment among racial/ethnic minority groups. Na-
tional  Health  and  Nutrition  Examination  Survey  data  for
1988–1994 to 1999–2004 showed that racial/ethnic disparities in
cardiovascular disease risk factors between non-Hispanic whites
and non-Hispanic blacks and between non-Hispanic whites and
Mexican Americans did not improve; for some health outcomes,
such as obesity and hypercholesterolemia, the gap even widened
(29).
No overall birth cohort effects were observed in our study, al-
though the cohort 1918–1922 was less likely than other cohorts to
self-report cognitive impairment, whereas the 2 youngest cohorts
(ie, 1948–1952 and 1953–1957) were more likely than other co-
horts to self-report cognitive impairment. Finally, we found a sig-
nificant interaction effect between education and race (except in
Hispanics), indicating a similar effect of education on cognitive
impairment across groups. Education levels have increased in the
United States in the past several decades (30), and education is
shown to protect against cognitive decline (31). A higher level of
education may contribute to the ability to recognize cognitive de-
cline. Education could explain why younger birth cohorts were
more likely than older cohorts in our study to report cognitive
impairment. Thus, our study indicates that the role of education in
self-reported cognitive impairment is twofold: a higher level of
education protects against cognitive decline and contributes to
greater self-awareness of cognitive impairment.
The data used in our study have several limitations. First, the data
were self-reported and thus are subject to reporting bias. Respond-
ents may intentionally withhold information because of stigma, or
they may not have been able to provide a reliable answer because
they were cognitively impaired. Self-reported cases of cognitive
impairment cannot be validated through clinical assessment. Also,
proxy-reported data could introduce bias. Proxies might misreport
the information for various reasons, including lack of knowledge
and stigma. However, studies showed that proxy-reported data on
cognition status of family members may be more reliable than
self-reported data (32). Second, the sample size for the Native
American group was small for calculating yearly estimates. Fu-
ture surveys should increase the sample size for the Native Ameri-
can group because Native Americans are at higher risk of many
chronic diseases that are associated with cognitive impairment, in-
cluding cardiovascular disease and diabetes (14). Third, our study
did not include residents in long-term care facilities, who are more
likely to be cognitively impaired than community-dwelling older
adults.
From 1997 to 2015, NHIS data showed that the overall rate of
self-reported cognitive impairment increased among the 5 major
racial/ethnic groups in the United States. However, by racial/eth-
nic group, the increasing trend was significant only among the
non-Hispanic white group. Significant racial/ethnic disparities per-
sisted during the study period. Our findings may reflect an in-
creased self-awareness  of  cognitive  impairment  in  the  United
States. They also underscore the need to further promote aware-
ness  of  cognitive  impairment,  especially  among  racial/ethnic
minority populations. Health education is needed for individuals,
family members, and health care providers to improve awareness
and knowledge of signs and early symptoms of Alzheimer’s dis-
ease and other forms of dementia.
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Tables
Table 1. Sample Characteristics, by Race/Ethnicity, National Health Interview Survey, 1997–2015
Variable
Non-Hispanic
White, %
(n = 116,445)
Non-Hispanic
Black, %
(n = 19,975)
Native American,
%
(n = 796)
Hispanic, %
(n = 15,553)
Asian, %
(n = 2,913) P Valuea
Age, y
60–64 28.4 32.5 35.0 32.8 32.9
<.001
65–69 22.5 24.0 22.8 25.6 25.3
70–74 18.5 18.7 19.7 18.6 18.3
75–79 12.6 11.0 9.4 11.2 10.4
80–84 9.3 7.3 7.9 6.7 6.4
≥85 8.7 6.6 5.1 5.3 6.7
Female 55.0 58.9 51.7 55.7 51.8 <.001
Married or living with partner 63.1 42.1 51.0 58.3 70.4 <.001
Some college or more 48.5 34.3 39.2 24.9 62.1 <.001
Ratio of family income to federal poverty level
<150% 17.4 41.5 38.6 42.3 22.9
<.001
150%–249% 22.0 21.9 23.5 23.3 16.0
250%–499% 33.6 24.1 22.8 23.3 28.8
≥500% 27.1 12.6 15.1 11.1 32.3
Chronic disease
Heart attack 10.2 8.4 14.2 7.5 6.4 <.001
Diabetes 15.7 28.3 31.4 27.3 20.6 <.001
High blood pressure 53.8 71.5 62.9 55.2 55.9 <.001
Coronary heart disease 13.4 11.0 16.6 10.3 10.3 <.001
Stroke 7.1 9.9 10.9 7.0 6.0 <.001
Body mass index, kg/m2
<18.5 2.0 1.5 2.8 1.1 3.4
<.001
Normal (18.5–24.9) 33.8 24.8 26.8 26.4 53.9
Overweight (25.0–29.9) 36.8 35.3 33.4 40.5 30.5
Obese (≥30.0) 27.5 38.4 37.0 32.0 12.1
a According to χ2 tests.
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Table 2. Weighted Prevalence of Cognitive Impairment, by Racial/Ethnic Group, National Health Interview Survey,1997–2015
Year
Percentage
Non-Hispanic White Non-Hispanic Black Native Americana Hispanic Asian Overall
1997 5.2 9.1 NA 9.3 NA 5.7
1998 5.0 8.0 6.5 6.2 7.4 5.4
1999 4.3 7.5 9.1 6.5 3.7 4.7
2000 5.0 10.2 12.7 7.3 9.4 5.6
2001 5.6 11.1 20.6 8.9 6.1 6.3
2002 6.0 8.6 20.6 7.5 14.7 6.5
2003 6.0 11.4 13.7 7.0 7.3 6.6
2004 5.9 8.3 7.6 8.1 7.6 6.3
2005 6.2 9.9 9.6 8.3 7.8 6.7
2006 5.7 9.8 13.5 7.5 6.2 6.2
2007 6.2 12.3 14.1 8.1 8.1 6.9
2008 5.3 9.1 10.3 6.1 7.0 5.8
2009 6.1 11.4 10.1 6.6 4.4 6.6
2010 6.0 8.4 11.4 8.4 5.6 6.4
2011 6.5 10.2 13.3 8.7 10.7 7.2
2012 5.8 9.5 15.3 9.3 6.1 6.5
2013 6.3 10.8 16.0 8.0 6.1 6.9
2014 6.2 9.7 16.9 8.9 5.0 6.8
2015 6.1 9.2 16.2 8.7 5.3 6.7
P value for trend <.001 .30 .27 .15 .28 <.001
a 3-year average.
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Table 3. Hierarchical Age–Period–Cohort Cross-Classified Model Results of Factors Associated With Self-Reported Cognitive Impairment, National Health Interview
Survey,1997–2015
Variable B (Standard Error) P Value
Fixed effects
Intercept −2.15 (0.05) <.001
Age (centered) 0.04 (0) <.001
Age2 0 (0) <.001
Sex
Male Reference
Female −0.07 (0) <.001
Marital status
Not married or living with partner Reference
Married or living with partner −0.33 (0) <.001
Race/ethnicity
Non-Hispanic white Reference
Non-Hispanic black 0.37 (0) <.001
Native American 0.87 (0.01) <.001
Hispanic 0.25 (0) <.001
Asian 0.31 (0.01) <.001
Education
<Some college or more Reference
Some college or more −0.20 (0) <.001
Ratio of family income to federal poverty level
<150% Reference
150%–249% −0.33 (0) <.001
250%–499% −0.43 (0) <.001
≥500% −0.83 (0) <.001
Body mass index, kg/m2
Underweight (<18.5) Reference
Normal (BMI 18.5–24.9) −0.65 (0) <.001
Overweight (BMI 25.0–29.9) −0.93 (0) <.001
Obese (≥30.0) −0.74 (0) <.001
Chronic diseasea
Heart attack 0.16 (0) <.001
Diabetes 0.47 (0) <.001
High blood pressure 0.09 (0) <.001
Coronary heart disease 0.32 (0) <.001
Stroke 1.44 (0) <.001
Race/ethnicity × college or more
Non-Hispanic white × college or more Reference
a Reference group for each category is absence of the disease.
(continued on next page)
PREVENTING CHRONIC DISEASE VOLUME 15, E06
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY     JANUARY 2018
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
10       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2018/17_0338.htm
(continued)
Table 3. Hierarchical Age–Period–Cohort Cross-Classified Model Results of Factors Associated With Self-Reported Cognitive Impairment, National Health Interview
Survey,1997–2015
Variable B (Standard Error) P Value
Non-Hispanic black × college or more −0.06 (0.01) <.001
Native American × college or more −0.20 (0.02) <.001
Hispanic × college or more −0.01 (0.01) .13
Asian × college or more −0.27 (0.01) <.001
Random effects
Survey period 0.01 (0) .001
1997 −0.10 (0.03) .001
1998 −0.17 (0.03) <.001
1999 −0.26 (0.03) <.001
2000 −0.14 (0.03) <.001
2001 0.03 (0.03) .35
2002 0.03 (0.03) .32
2003 0.05 (0.03) .04
2004 −0.03 (0.03) .21
2005 0.12 (0.03) <.001
2006 −0.01 (0.03) .58
2007 0.15 (0.03) <.001
2008 −0.18 (0.03) <.001
2009 0.04 (0.03) .12
2010 0.07 (0.03) .02
2011 0.13 (0.03) <.001
2012 0.05 (0.03) .08
2013 0.09 (0.03) .001
2014 0.13 (0.03) <.001
2015 0.00 (0.03) .98
Cohort 0.01 (0.01) .02
1912–1917 0.01 (0.04) .78
1918–1922 −0.15 (0.04) <.001
1923–1927 −0.06 (0.04) .14
1928–1932 −0.07 (0.04) .06
1933–1937 0.00 (0.04) .93
1938–1942 −0.07 (0.04) .07
1943–1947 −0.03 (0.04) .45
1948–1952 0.19 (0.04) <.001
1953–1957 0.18 (0.04) <.001
a Reference group for each category is absence of the disease.
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